DK1448559T3 - 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolodin-2,4-dionbenzensulfat; fremgangsmåde til dets fremstilling; polymorf i, II og III deraf; og dets anvendelse som farmaceutisk aktiv bestenddel - Google Patents

5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolodin-2,4-dionbenzensulfat; fremgangsmåde til dets fremstilling; polymorf i, II og III deraf; og dets anvendelse som farmaceutisk aktiv bestenddel

Info

Publication number
DK1448559T3
DK1448559T3 DK02779711T DK02779711T DK1448559T3 DK 1448559 T3 DK1448559 T3 DK 1448559T3 DK 02779711 T DK02779711 T DK 02779711T DK 02779711 T DK02779711 T DK 02779711T DK 1448559 T3 DK1448559 T3 DK 1448559T3
Authority
DK
Denmark
Prior art keywords
pyridyl
ethoxy
benzyl
amino
methyl
Prior art date
Application number
DK02779711T
Other languages
Danish (da)
English (en)
Inventor
Andrew Simon Craig
Michael John Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0127934A external-priority patent/GB0127934D0/en
Priority claimed from GB0127937A external-priority patent/GB0127937D0/en
Priority claimed from GB0127935A external-priority patent/GB0127935D0/en
Priority claimed from GB0127936A external-priority patent/GB0127936D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of DK1448559T3 publication Critical patent/DK1448559T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
DK02779711T 2001-11-21 2002-11-21 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolodin-2,4-dionbenzensulfat; fremgangsmåde til dets fremstilling; polymorf i, II og III deraf; og dets anvendelse som farmaceutisk aktiv bestenddel DK1448559T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0127934A GB0127934D0 (en) 2001-11-21 2001-11-21 Novel compounds
GB0127937A GB0127937D0 (en) 2001-11-21 2001-11-21 Novel compounds
GB0127935A GB0127935D0 (en) 2001-11-21 2001-11-21 Novel compounds
GB0127936A GB0127936D0 (en) 2001-11-21 2001-11-21 Novel compounds
PCT/GB2002/005232 WO2003045946A1 (en) 2001-11-21 2002-11-21 5-(4-(2-(n-methyl-n-(2-pyridil) amino) ethoxy) benzyl) thiazolidine-2, 4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thereof; and its use as pharmaceutical active ingredient

Publications (1)

Publication Number Publication Date
DK1448559T3 true DK1448559T3 (da) 2007-04-30

Family

ID=27448006

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02779711T DK1448559T3 (da) 2001-11-21 2002-11-21 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolodin-2,4-dionbenzensulfat; fremgangsmåde til dets fremstilling; polymorf i, II og III deraf; og dets anvendelse som farmaceutisk aktiv bestenddel

Country Status (14)

Country Link
EP (1) EP1448559B1 (zh)
JP (1) JP2005513038A (zh)
KR (1) KR20040062963A (zh)
CN (1) CN100390170C (zh)
AT (1) ATE349444T1 (zh)
AU (1) AU2002343050A1 (zh)
CY (1) CY1106397T1 (zh)
DE (1) DE60217168T2 (zh)
DK (1) DK1448559T3 (zh)
ES (1) ES2278977T3 (zh)
HK (1) HK1068884A1 (zh)
PT (1) PT1448559E (zh)
SI (1) SI1448559T1 (zh)
WO (1) WO2003045946A1 (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) * 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0021784D0 (en) * 2000-09-05 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
CN1310912C (zh) * 2000-12-22 2007-04-18 史密丝克莱恩比彻姆有限公司 5－[4－[2－(n－甲基－n－(2－吡啶基)氨基)乙氧基]苄基]噻唑烷－2,4－二酮甲磺酸盐

Also Published As

Publication number Publication date
SI1448559T1 (sl) 2007-06-30
JP2005513038A (ja) 2005-05-12
EP1448559B1 (en) 2006-12-27
CN1612875A (zh) 2005-05-04
PT1448559E (pt) 2007-03-30
CY1106397T1 (el) 2011-10-12
WO2003045946A1 (en) 2003-06-05
KR20040062963A (ko) 2004-07-09
AU2002343050A1 (en) 2003-06-10
HK1068884A1 (en) 2005-05-06
ATE349444T1 (de) 2007-01-15
EP1448559A1 (en) 2004-08-25
DE60217168T2 (de) 2007-10-04
CN100390170C (zh) 2008-05-28
ES2278977T3 (es) 2007-08-16
DE60217168D1 (de) 2007-02-08

Similar Documents

Publication Publication Date Title
CY1106226T1 (el) Μεσυλικο αλας 5-[4-[2-(ν-μεθυλ-ν-(2-πυριδυλ)αμινο)αιθοξυ]βενζυλ]θειαζολιδινο-2,4-διονης
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
EA200300234A1 (ru) Тартратные соли производного тиазолидиндиона
DK1446404T3 (da) Rosiglitazonedisylater og deres anvendelse som antidiabetika
DK1448559T3 (da) 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolodin-2,4-dionbenzensulfat; fremgangsmåde til dets fremstilling; polymorf i, II og III deraf; og dets anvendelse som farmaceutisk aktiv bestenddel
AP1715A (en) The hydrochloride salt of 5-[ 4 -[2 -(n-methyl-n- (2-pyridyl) amino) ethoxy]benzyl]thiazolidine -2,4-dione
NO20076517L (no) Natriumsalter av 5-[4-[2-(N-metyl-N-(2-pyridyl)amino)etoksyl]benzyl]tiazolidin-2,4-dion
DK1315721T3 (da) Et Thiazolidindionderivat og dets anvendelse som et antidiabetisk middel
NO20075507L (no) Tiazolidindionderivater og deres anvendelse som antidiabetiske midler
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
MXPA02012100A (es) Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
EA200300232A1 (ru) Тартратные соли производного тиазолидиндиона